Fischer Medical Ventures Limited has informed regarding Disclosure of material issue
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Limited's board has approved a sub-division/split of equity shares in the ratio of 1:10 — each existing equity share of face value Rs. 10 will be split into 10 equity shares of face value Re. 1. The total paid-up share capital (Rs. 64,55,15,470) and authorized capital (Rs. 80,00,00,000) remain unchanged in value terms, but the share count will multiply 10-fold to 64,55,15,470 paid-up shares. The split is subject to shareholder approval via postal ballot, with e-voting scheduled from 31-07-2025 to 30-08-2025 and results expected by 02-09-2025. The company says the rationale is to make shares more affordable for retail investors and improve liquidity. The board also approved consequential amendments to the Capital Clause (Clause V) of the Memorandum of Association and appointed M/s Nuren Lodaya & Associates as scrutinizer.
If approved, the stock price will mechanically adjust downward by a factor of 10 (e.g., a share trading at Rs. 500 will theoretically move to around Rs. 50). The move is intended to improve liquidity and broaden retail participation, which is generally viewed positively. No change in total investment value or company fundamentals — existing shareholders automatically receive 10 shares for every 1 held. Watch for the postal ballot outcome on 02-09-2025.